Difficulty: Medium
Average Score: 65%
Practice
A 55-year-old woman undergoes surgery. She receives several drugs for preoperative care and intraoperative. Toward the end of the procedure she develops hyperthermia, hypertension, hyperkalemia, muscle rigidity, and metabolic acidosis. Which of the following drugs is most likely to have participated in this reaction?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Halothane. Halothane is a volatile anesthetic that can cause a rare but serious condition known as malignant hyperthermia (MH). MH is a potentially life-threatening reaction triggered by certain anesthetics, causing symptoms like hyperthermia, hypertension, muscle rigidity, hyperkalemia, and metabolic acidosis.
Fentanyl (A) is an opioid analgesic commonly used in anesthesia, but it does not typically cause the constellation of symptoms seen in MH. Ketamine (C) is a dissociative anesthetic that is not associated with MH. Midazolam (D) is a benzodiazepine used for sedation and anxiety relief, and it is not known to cause MH.
Educationally, understanding the potential adverse effects and reactions of different CNS drugs is crucial for healthcare providers involved in administering anesthesia. Recognizing the signs of MH and knowing which drugs can trigger it is essential for prompt identification and management to ensure patient safety during surgical procedures. Training in pharmacology helps healthcare professionals make informed decisions and respond effectively to unexpected reactions like malignant hyperthermia.
Fentanyl (A) is an opioid analgesic commonly used in anesthesia, but it does not typically cause the constellation of symptoms seen in MH. Ketamine (C) is a dissociative anesthetic that is not associated with MH. Midazolam (D) is a benzodiazepine used for sedation and anxiety relief, and it is not known to cause MH.
Educationally, understanding the potential adverse effects and reactions of different CNS drugs is crucial for healthcare providers involved in administering anesthesia. Recognizing the signs of MH and knowing which drugs can trigger it is essential for prompt identification and management to ensure patient safety during surgical procedures. Training in pharmacology helps healthcare professionals make informed decisions and respond effectively to unexpected reactions like malignant hyperthermia.